Announcing Exciting New Functionality for FC+ Forecasting Software
31st March 2023J+D are pleased to be bringing even more value to our clients with an update to our FC+ software suite.
What is pharmaceutical forecasting
19th January 2023An interview by News Medical with David James, CEO J+D Forecasting about pharmaceutical forecasting, J+D Forecasting solutions and their plans for the future.
How to Model for Loss of Exclusivity and Generic Entrants
29th March 2023Whether a direct threat to your originator brand, or a competitor brand losing patent, either way, it is important to build the impact into your forecast structure.
Taking the right forecasting approach for rare diseases
8th December 2022Generating accurate forecasts for rare diseases can be challenging, especially when the treatable population is in the hundreds and there is little data to get you from one number to the next.
J+D release FC365 Lite
20th March 2023For pharma clients looking to take their first steps into an integrated forecasting solution.
‘What if’ there was a way to make scenario analysis quick and easy
14th November 2022Carrying out ‘what-if’ analysis is a way for key stakeholders in forecasting to immediately explore the impact of changing key assumptions and ultimately make better decisions. FC365 makes this easy.
J+D develop ‘Goal Seeker’ tool for enhanced pharmaceutical forecasting
25th November 2022Announcing the development of a forecasting tool to bring the analyst’s tool kit to the next level.
FC+ Continues to go from strength to strength
3rd November 2022Innovating our suite of forecasting software for independent pharmaceutical forecasting.
Our great suite of forecasting software just got better!
8th June 2022Sales+, part of the FC+ family, has had an exciting development - unique Auto-trending functionality has been added to the existing features.
The Benefits of SaaS For Pharmaceutical Forecasting.
5th January 2022Learn why SaaS is becoming essential within the pharmaceutical forecasting environment.
The Fundamental Pillars that Support Good Forecasting
21st June 2017The Context Here at J+D we create 100’s of strategic forecasting and operational planning models for many of the largest pharmaceutical companies year on year. These figures have increased consistently, certainly in the last 5-7 years; as scrutiny from pharmaceutical investors puts increasing pressure on revenue…